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A b s t r a c t: Aim: To describe the various strategies for the control and eradi-
cation of B. melitensis infection in sheep and goats. 
Methods: The advantages and drawbacks of these strategies are discussed on 
the basis of the author’s personal experience and a revision of the relevant literature.  
Results: Vaccination programmes in various combinations can be applied eit-
her to decrease the prevalence of infection in the animal population or, when combined 
with adequate complementary eradication measures, to achieve a brucellosis-free status. 
Conclusion: Controlling the disease should be the primary goal of the veteri-
nary services involved. However, eradication should be the final objective of any con-
trol programme implemented. The selection of an eradication or control strategy is of 
paramount relevance, and a frequent cause of controversy among decision-makers. The 
final strategy should be established according to the quality of the veterinary services 
organisation, the economic resources available and the extent and prevalence of disease. 
Cooperation with farmers is essential to succeed with the application of even the most 
elementary control programme. When brucellosis is highly prevalent, mass (whole-
flock) vaccination is the choice to control the disease, independently of the socioecono-
mic situation. Once effective control of the disease has been accomplished, its eradica-
tion is feasible. For successful eradication, the adequate quality and organisation of ve-
terinary services, the strict control of animal movements and the provision of adequate 
economic compensation to affected farmers are compulsory. When the disease is fully 
eradicated, a surveillance strategy has to be implemented for the early detection of even-
tual new outbreaks or disease reintroduction. 
Key words: brucellosis, Brucella melitensis, zoonosis, vaccination, control/eradication 
strategies. 
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Introduction 
 
 Brucellae are Gram-negative, facultative, intracellular bacteria showing 
a wide range of species-specificity and causing important diseases in both hu-
mans and animals. At present, eight species are recognised: B. abortus (affec-
ting mainly cattle), B. melitensis (sheep and goats), B. suis (swine), B. neotomae 
(desert rats), B. ovis (sheep), B. canis (dog), B. ceti (cetaceans) and B. pinnipe-
dialis (pinnipeds). A couple of new species: B. microti (isolated from common 
voles) and B. inopinata (isolated from a human patient) have been proposed but 
not yet accepted by the Taxonomy Subcommittee on Brucella. With the excep-
tion of B. ovis and B. neotomae, all the accepted species are pathogenic for hu-
mans. In human beings, brucellosis is one of the most important and universally 
distributed zoonotic diseases. Swine brucellosis (due to B. suis) is an important 
disease in many parts of the world (essentially America, Asia and Oceania), but 
brucellosis of cattle, sheep and goats are the most relevant from the socio-eco-
nomic point of view, and are generally submitted to official control campaigns 
all over the world. Brucellosis in cattle (caused by Brucella abortus infection) is 
a disease eradicated or practically eradicated in many developed countries, but 
remains highly prevalent in many parts of the developing world. Brucella meli-
tensis is the main species responsible of brucellosis in sheep and goats (alt-
hough in extensive breeding systems it affects frequently also cows, yaks, ca-
mels and buffaloes), and is a disease highly prevalent in many countries, most 
having great difficulty in controlling this infection. Moreover, B. melitensis is 
highly zoonotic and the responsible for the vast majority of human brucellosis 
cases around the world. Despite the considerable increase in scientific know-
ledge of brucellosis in the recent past, many aspects concerning this disease in 
sheep and goats remain yet unknown, unclear, and are frequently controversial. 
However, even though some basic aspects of brucellosis pathogenesis require 
additional research, the diagnostic and prophylactic tools have been sufficiently 
validated and standardised, and are widely available to control the disease in 
most parts of the world. In my opinion, success in eradicating brucellosis in 
small ruminants is largely dependant on the quality of the veterinary services 
and administrative organisations involved, rather than on any deficiencies of 
either diagnostic or prophylactic tools. The aim of this review is to describe the 
different strategies that could be applied to either the control or eradication of 
brucellosis in sheep and goats. 
 
 
Epidemiology and clinical aspects 
 
  B. melitensis infection appears to occur naturally in the Mediterranean 
region, but infection is widespread world-wide. Canada and the USA are free of 
 Control and eradication strategies… 147 
Прилози, Одд. биол. мед. науки, XXXI/1 (2010), 147–165 
this disease, as are Northern Europe, Southeast Asia, Australia and New Zea-
land [1]. B. melitensis infection of small ruminants is quite similar in both 
pathological and epidemiological standpoints to B. abortus infection of cattle. 
The main clinical manifestations of brucellosis in ruminants are reproductive 
failure (i.e. abortion and birth of offspring that do not thrive), orchitis and epidi-
dymitis. Arthritis is an infrequent sign. B. melitensis biovars 1 and 3 appear to 
be the most frequently isolated strains in small ruminants in Mediterranean and 
Middle-East countries. There is no evidence according the different biovars iso-
lated that either the epidemiological or clinical features of infections in rumi-
nants can be variable. Only when the animals excrete the bacterium do they be-
come dangerous to other animals and human beings. In most circumstances, the 
primary (and more relevant from the epidemiological standpoint) excretion ro-
ute of B. melitensis is the placenta, foetal fluids and vaginal discharges expelled 
by infected animals after abortion or full-term parturition. Shedding of B. meli-
tensis is also common in udder secretions and semen. Brucella may be isolated 
from various tissues, such as lymph nodes from the head and those associated 
with reproduction, and from arthritic lesions [2]. As happens in B. abortus in-
fection of cattle, B. melitensis can be transmitted congenitally in sheep and 
goats. Most latent infections in cattle take place through in utero transmission. 
However, only a small proportion of lambs and kids are infected in utero, and 
the majority of B. melitensis latent infections are probably acquired through co-
lostrum or milk [3]. It is also probable that a self-cure mechanism similar to that 
suggested in cattle takes effect in most perinatally infected lambs [3]. Despite 
the low frequency of transmission, the existence of such latent infections increa-
ses the difficulty of eradicating this disease, as the bacteria persist in the animal 
without inducing detectable immune responses. The exact mechanism of the 
development of B. melitensis latent infections remains unknown [3].  
 In many parts of the world, small ruminants and cattle (and frequently 
also camels, yaks and buffaloes) are reared together. In these production sys-
tems the existence of cross-infections is very frequent with B. melitensis being 




Control and eradication programmes 
 
 An important problem faced by the veterinary authorities in countries 
affected by brucellosis is to select the sanitary strategy to be applied against the 
disease. Adequate organisation of veterinary services is, without any doubt, the 
most important element to be taken into consideration by decision-makers pre-
vious to any potential selection of a sanitary programme. The recent experience 
in the EU demonstrates that no sanitary strategy can be applied in the absence of 
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a minimum of capacity, quality and adequate organisation in the veterinary 
services involved. Even for implementing the simplest control strategy (i.e. a 
mass vaccination programme), the veterinary services involved should have a 
proper organisation to identify all flocks present in the country and apply the 
vaccine to the whole population in a very short time interval. In the case where 
the organisation of veterinary services is adequate, the strategy to be applied 
should then be decided according the economic resources available, the degree 
of involvement of farmers, and the extent and prevalence of the disease. 
 The economic costs of eradication programmes are very important, and 
financial resources should be allocated to support the programme as an essential 
requisite prior to the selection of any eradication strategy. The practical experi-
ence of many countries that succeed with B. melitensis eradication also demon-
strates that adequate economic compensation (i.e. equivalent to the real market 
value of animals culled) to affected farmers has to be provided. Moreover, to be 
successful, the full operative costs of interventions have also to be covered by 
the public administration concerned.  
 The adequate organisation and involvement of shepherds is also another 
essential requisite for success in the implementation of even the simplest control 
strategy based on mass vaccination. Therefore, in addition to implementing ade-
quate compensation (i.e. subsidising vaccination and operative costs, indemni-
sation of animals slaughtered, etc), adequate awareness campaigns should be 
addressed to the affected farmers with the objective of getting full agreement 
with the strategy decided. No success in implementing any control or eradica-
tion programme should be expected without the active involvement of the affec-
ted owners. 
 Provided that the veterinary services organisation, farmers’ involvement 
and economic resources are fully adequate, the final elements to be considered 
by decision-makers are i) assessing the real situation of brucellosis (i.e, identi-
fying the bacterial and animal species involved, and also the collective preva-
lence), and ii) defining the minimal epidemiological unit of intervention. The 
bacterial species and biovars involved should be identified though an active 
bacteriological search, in close collaboration with national and international la-
boratories with proven competence in Brucella typing. The collective preva-
lence (i.e. percentage of infected flocks) of disease has to be determined follo-
wing a technically adequate epidemiological survey, and always taking into 
consideration the important differences in prevalence that should be expected 
between different regions within the same country or epidemiological unit of 
intervention. A frequent error of decision-makers is tending to “homogenise” 
the level of prevalence calculating “mean prevalence” figures for the whole 
country or particular region considered. However, prevalence is infrequently 
homogeneous and, in most cases, the territorial extension considered is repre-
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sented by a combination of different epidemiological situations. Accordingly, 
decision-makers should avoid the use of generalised measures, and be ready to 
apply different strategies adequate to each of the different epidemiological situ-
ations identified. A given territorial extension with a similar epidemiological 
situation should be considered as the minimal epidemiological unit of interven-
tion. In some cases this unit could be a couple of isolated sheep and camel flo-
cks in a village, sometimes the whole sheep and goat flocks in a county, and 
more frequently, the whole flocks of all animal species involved in a country or 
region. It is essential to take into consideration that B. melitensis infection has 
no administrative borders, and decision-makers should consider this when imp-
lementing control or eradication strategies in the neighborhood of other coun-
tries affected by the disease. On many occasions, particularly in extensive and 
transhumant breeding systems, the minimal epidemiological unit of intervention 
is of a transboundary nature. 
 Once the professional organisation and the economic resources are fully 
adequate, the epidemiological unit of intervention should be defined. Whenever 
the collective prevalence (percentage of infected flocks) in this unit be unifor-
mly very low (always less than 1% of flocks infected), a strategy based on a test 
and slaughter programme and a ban on vaccination could be applied to eradi-
cate the disease in the short to medium term in that particular epidemiological 
unit. In the case where prevalence is uniformly moderate, a combined eradica-
tion programme based on the simultaneous application of vaccination in young 
replacements (3–4 months old animals) and a test and slaughter in adult animals 
could be recommended to eradicate the disease in the medium to long term. Ho-
wever, when the disease is highly prevalent (more than 10% of flocks are 
infected), even though the professional organisation and the economic resources 
be fully adequate, the mass (whole-flock) vaccination of all animals from all 
animal species involved in the epidemiological cycle is the only reasonable stra-
tegy that can be applied to control the disease.  
 For success in the application of the last two strategies, the use of ade-
quate vaccines and vaccination procedures is of paramount relevance. 
 
 
Vaccines and vaccination procedures 
 
 1. Classical vaccines 
 Despite its important drawbacks, the live B. melitensis Rev 1 vaccine is 
considered the best vaccine available for the prophylaxis of B. melitensis infe-
ction in sheep and goats. When used in well conducted whole-flock vaccination 
programmes repeated in time, a great decrease in brucellosis prevalence is ob-
tained in most situations [4–6]. However, when this vaccine is administered by 
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the classical method (individual doses of 1–2 × 109 CFU applied subcutaneou-
sly), a long-lasting serological response is induced in vaccinated animals, ma-
king it difficult to interpret serological tests applied after vaccination. Accordin-
gly, this classical vaccination method makes the combined eradication program-
me mentioned above practically inapplicable. However, when Rev 1 is admi-
nistered by the conjunctival method (the same 1–2 × 109 CFU individual stan-
dard dose but applied by conjunctival instillation in a small volume -30/50 mic-
rolitres), the immunity conferred is similar to that induced by the classical sub-
cutaneous method but the serological responses evoked are significantly redu-
ced. In fact, this conjunctival procedure is the only available tool fully compati-
ble with the successful application of the combined eradication programme in 
small ruminants [6, 7].  
 As commented above, a whole-flock vaccination programme is the only 
feasible alternative to control B. melitensis infection in high prevalence situa-
tions, and under the poor socio-economic conditions and extensive breeding 
systems characteristics of many countries. In these situations, the serological 
interferences caused by Rev 1 are fully irrelevant, and then the administration 
route would be of little importance. However, the vaccination of pregnant ani-
mals with standard doses (1–2 x 109 CFU) of Rev 1 administered subcutaneo-
usly is followed by huge numbers of vaccine-induced abortions and the excre-
tion of Rev 1 strain in the milk of many animals. These side-effects are reduced 
but not abrogated when Rev 1 is administered conjunctivally [6, 8]. Reducing 
the dose of Rev 1 has been suggested as a method of minimising or fully avoi-
ding these important side-effects and accordingly, a reduced dose vaccination 
procedure (undefined individual doses ranging 103–107 CFU and administered 
subcutaneously) has been widely used and reported as safe and effective enough 
for controlling brucellosis in small ruminants [4, 9, 10]. However, field and 
experimental experience in sheep has demonstrated beyond doubt that this is not 
true. Due to the induction of abortion in pregnant animals and the low degree of 
immunity conferred (for a review see ref. 6 – Blasco 1997), the reduced doses 
of Rev 1 – even when administered conjunctivally – should never be recom-
mended as an alternative to vaccination with the standard doses (1–2 × 109 
CFU). 
  A mass vaccination including adult animals (males and females) is the 
simplest control method, and frequently the only reasonable strategy to be ap-
plied in high prevalence situations and extensive breeding conditions. Unfortu-
nately, due to the induction of abortions when vaccinating pregnant sheep and 
goats, there is no entirely safe strategy for using Rev 1 in these conditions. Even 
considering that conjunctival vaccination with Rev 1 is safer than subcutaneous 
vaccination for mass vaccination purposes, this procedure is not safe enough to 
be applied regardless of the pregnancy status of the animals (for a review see 
ref. 6 – Blasco, 1997). Accordingly, Rev 1 vaccine should be used only under 
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restricted conditions avoiding whenever possible vaccination during mid preg-
nancy, which is the main critical period [6, 8, 11]. This, however, is impractical 
under field conditions, and some of the above side-effects have to be assumed 
by both decision-makers and farmers. Field experience in many countries has 
demonstrated that conjunctival vaccination with standard doses of Rev 1 (1–2 × 
109 CFU) during the prebreeding period, late lambing season and lactation is the 
optimal window of opportunity to perform a whole-flock vaccination prog-
ramme with the minimum of induced side-effects (for a review see the ref. 6 – 
Blasco, 1997). Another drawback of Rev 1 (that has been proven of little human 
health significance after more than 50 years of widespread use of this vaccine) 
is that it can infect humans [12] and, moreover, this strain is resistant to 
streptomycin, the antibiotic that combined with doxycycline provides the most 
effective brucellosis therapy [13]. Accordingly, awareness campaigns addressed 
to people involved in vaccination and minimal individual biosafety measures 
have to be implemented during vaccination to lessen the Rev 1 risks in human 
beings. In the case of accidental human infection with Rev 1, a combined 
doxycycline-gentamicin (or doxycycline-rifampin) has to be used [12, 13]. 
 Despite the above drawbacks of Rev 1, it is important to stress that 
several million animals all over the world have been repeatedly mass vaccinated 
with this vaccine, and no Rev 1 epidemics in both animals and human beings 
have been reported in any country.  
 
 2. Other vaccines  
 New vaccines can be classified depending on the generation method 
used, either by classical techniques or by mutagenesis or genetic engineering. 
Among the live rough Brucella strains obtained by classical attenuation met-
hods is the B. abortus RB51 vaccine. This strain has been considered to be as 
effective as the classical B. abortus S19 vaccine in protecting against B. abortus 
in cattle, with the additional advantage of not inducing anti – O polysaccharide 
antibodies interfering with classical serological tests (Rose Bengal – RB – and 
Complement Fixation – CF – tests), whereas it does in enzyme immunoassays 
(ELISAs) [14]. Moreover, the protective efficacy and safety of this vaccine in 
cattle are controversial, and remain to be properly established [14, 15]. In sheep, 
it has been clearly shown that RB51 is not effective enough against B. meliten-
sis [16] or B. ovis [17] infections. Moreover, even though the risks are low, 
human infections due to RB51 have also been described [18], and this mutant is 
resistant to rifampin, the antibiotic that, combined with doxycycline, is widely 
used for treating brucellosis in humans [13]. Taking all the above comments 
into consideration, RB51 should never be recommended for vaccination in 
small ruminants. 
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 VTMR1 and VTSR1 are two live rough strains obtained by transposing 
mutagenesis from B. melitensis 16M and B. suis 2579, respectively. Mutagene-
sis in these strains results in mutation of the wboA gene coding for mannosyl-
transferase, an enzyme required for the S-LPS O-polysaccharide synthesis. 
Accordingly, these strains do not induce antibodies against the O-polysaccha-
ride and, similarly to RB51, do not interfere with classical serological tests (RB 
and CF tests). Both strains are attenuated in mice but VTMR1 resulted in poor 
protective efficacy against B. melitensis in goats [19, 20]. 
 Recently, B. melitensis R mutants in all main lipopolysaccharide (S-
LPS) biosynthetic pathways have been obtained [21] and evaluated for ability to 
induce anti-O-polysaccharide antibodies, persistence and innocuousness, and 
efficacy against B. melitensis in sheep [22]. All these R mutant induced antibo-
dies caused interference in B. melitensis ELISA tests, and moreover, protection 
by the best R vaccines was 54% or less whereas Rev 1 afforded 100% protec-
tion against a challenge able to infect 100% of unvaccinated control ewes [22].   
 The main reason for developing R brucellosis vaccines is the lack of 
interference that these vaccines cause in classical serological tests (RB and CF 
tests). However, this advantage is not so clear when classical tests are replaced 
by immunosorbent assays using the S-LPS or its hydrolytic polysaccharides as 
antigens. An important proportion of R mutant vaccinated ewes became positive 
in an indirect ELISA [22]. This is not unexpected since R mutants elicit antibo-
dies to the core epitopes also present in the wild-type S-LPS and its hydrolytic 
polysaccharides. Core epitopes are not readily accessible on the whole S 
brucellae (used as antigen in the classical RB and CF tests), but they become 
exposed upon adsorption of those molecules to ELISA polystyrene plates and, 
therefore, prevent a clear-cut distinction of the antibody responses to S and R 
brucellae in immunosorbent assays. This is likely to be a problem affecting all 
R vaccines because we have found that a significant proportion of cows that 
aborted as a consequence of vaccination with RB51 develop antibodies reacting 
in an indirect ELISA performed with the S-LPS hydrolytic polysaccharide as 
antigen [15]. As a conclusion, the great potential advantages claimed for R vac-
cines have been seriously questioned, and there is increasing evidence showing 
that these vaccines interfere in S-LPS based immunosorbent assays, lack safety 
in pregnant animals, can be excreted in the milk of vaccinated animals, can in-
fect humans, and are less effective than classical Rev 1 and S19 vaccines aga-
inst brucellosis in small ruminants and cattle. 
 Other approaches to develop new generation vaccines, such as the con-
struction of recombinant strains deleted in relevant diagnostic proteins or DNA 
based vaccines, are also being investigated. A Rev 1 vaccine strain deleted in 
the gene coding for BP26 periplasmic protein (that can be used as a differential 
marker) resulted in the same protective efficacy as Rev 1 in sheep [23]. This 
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good efficacy was also evidenced against B. ovis in rams, but the performance 
of the BP26 based differential diagnostic test was only very limited [24]. 
 Up to now, none of these new generation vaccines have been found to 
improve the immunity or fully resolve the problems caused by the classical Rev 
1 vaccine. Accordingly, until new, safer and more effective vaccines are develo-
ped and tested properly, Rev 1 should continue to be the reference vaccine for 





 In many countries having organised but only elementary veterinary ser-
vices and limited economic resources, the Rev 1 based mass vaccination prog-
ramme is the only feasible alternative to be applied and maintained for many 
years, independently of the level of prevalence determined in the epidemiolo-
gical unit identified (usually the whole country). As commented above, the 
main practical problems generated when applying this programme are due to the 
drawbacks of Rev 1 vaccine when used in pregnant animals. An alternative 
safest control strategy classically recommended to avoid problems in adult vac-
cinated animals is based on the annual vaccination of young replacements (3–4 
months old) exclusively, a fully innocuous method lacking relevant side effects 
[25]. The hypothesis of this conservative but safest control strategy is that if 
100% of young replacements (which can usually represent 15–25% of the total 
population, depending on the breeding systems considered) are vaccinated each 
year, the total animal population will be fully immunised after a moderate pe-
riod of time (usually 4–8 years, according to the animal species and the husban-
dry systems considered). To be successful, the whole of the young replacement 
population (both males and females) should be vaccinated annually and, ideally, 
identified with a distinctive ear tag or suitable mark for adequate follow-up in 
the later years. However, due to the practical difficulties of getting full vaccine 
coverage of the whole population, this strategy has failed to control brucellosis 
even in favorable conditions in developed countries [6], and it is frequently 
inapplicable in the developing world. Finally, it has been proved unsuccessful in 
controling the disease in high prevalence conditions. In the characteristic exten-
sive husbandry conditions of ruminants, owners can keep young replacements 
all through the year according to grazing resources and market prices. There-
fore, several veterinary visits are required each year to achieve whole vaccina-
tion coverage of these young replacements. This important practical problem 
and the great difficulty in identifying flocks reared in nomadic or semi-nomadic 
breeding conditions, results in a failure of adequate vaccination coverage for the 
whole population, and the ensuing maintenance of the disease. 
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 Therefore, the whole-flock vaccination programme is the only feasible 
alternative to control brucellosis infection in ruminants under the extensive 
breeding practices characteristic of many countries. This mass vaccination could 
be accompanied or not with individual ear tagging (or alternative suitable iden-
tification procedures) of vaccinated animals. This individual identification could 
facilitate the adequate follow-up of the control programme in subsequent years 
(only unmarked animals should be vaccinated the next year). Unfortunately, ear 
tagging is not exempt from inconveniencies. First, it is not a fully suitable pro-
cedure for the permanent identification of the animals. Moreover, it is expensive 
(sometimes the cost of tags exceeds that of the vaccine), and it can be a cause of 
important problems of miasis when implemented in hot climates such as those 
of Mediterranean and SEE countries.  
 To be effective, any control programme based on mass vaccination has 
to be maintained over time. Once the first mass vaccination campaign has been 
applied in the whole population of the epidemiological unit considered, the ideal 
follow-up procedure to minimise the side effects of Rev 1 should consist of vac-
cinating exclusively the young replacements in the following years, and at least 
for the 8–10 years following the first mass vaccination. A distinctive ear tagging 
(or suitable individual identification) should also be recommended as the 
adequate follow up. Without any doubt this is the safest procedure because of 
the lack of side effects of Rev 1 when used in both young male and female rep-
lacements [25]. However, as has been indicated above, due to the practical diffi-
culties of vaccinating 100% of young replacements each year, this alternative 
can fail to control brucellosis even in the best socio-economic conditions [6]. 
 Another more practical alternative could be applied to reach the 
adequate vaccination coverage of the population in the years following the first 
intervention. The characteristic annual replacement figures for sheep and goats 
in extensive breeding systems usually range from 15–25%. Therefore, the next 
year after the application of the first mass vaccination a total of 15–20% of the 
population should be composed of new replacements, then unvaccinated and 
susceptible to the disease. However, it is highly improbable that B. melitensis 
infection would be maintained and extended by transmission to this relatively 
low percentage of unvaccinated young replacements (most of them unpregnant, 
and at that time out of the period of maximal risk of excretion and spreading). 
Accordingly, considering these low replacement figures and the relatively low 
risks of disease maintenance and spreading among this unvaccinated young rep-
lacement population, it could be acceptable to avoid repeating a new mass vac-
cination every year to maintain a 100% vaccination coverage. However, two 
years after the first mass vaccination has been performed, and no complemen-
tary vaccination has been applied to new young replacements (the safest alterna-
tive), around 30–50% of the animal population would be composed of unvacci-
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nated replacements, then fully unprotected, and with a relatively high proportion 
of animals at risk of the ensuing danger of disease maintenance and spreading. 
Therefore, a practical way to apply a cost-effective Rev 1 based mass vacci-
nation control strategy could be based on repeating vaccination in the whole po-
pulation every two years. Obviously, this repeated vaccination should again be 
conducted exclusively in the ideal window of opportunity (see above) trying to 
minimise Rev 1 side effects [6]. When combined with individual ear tagging (or 
suitable individual identification procedures), this could facilitate the avoidance 
of repeated vaccination in previously vaccinated (tagged) animals. In fact, se-
veral mass vaccination campaigns covering millions of animals have been or are 
being currently applied to control the disease in many countries, using this met-
hodology, combined or not with individual tagging. 
 Independently of the strategy chosen, the evaluation of the efficacy of 
mass vaccination cannot be established by means of serological surveys conduc-
ted at a short time interval after vaccination. First, the serological response indu-
ced by Rev 1 in adult animals is of high intensity and duration, being practically 
impossible to discriminate from that induced in infected animals. Moreover, 
taking it into consideration that infected animals are not culled but maintained 
in contact with healthy vaccinated animals, the serological background becomes 
even more complicated to interpret because of the anamnestic responses of vac-
cinated animals after having antigenic contacts with infected materials. In these 
conditions, a significantly higher number of reactors than before vaccination 
should be evidenced when conducting a serological survey after vaccination. 
The most practical way of assessing the efficacy of the mass vaccination stra-
tegy implemented is to demonstrate a decrease in the human cases in the follo-
wing years. However, a serological survey conducted soon after vaccination in a 
representative sample of the vaccinated population is recommended to assess 
that vaccination has been properly conducted. Reactors in the RB test should 
range from 80–100% when animals vaccinated adequately are tested 15–20 





 When any of the above basic mass vaccination strategies has been 
successfully applied and maintained for at least one entire generation (around 
6–12 years, depending on the animal species and breeding systems considered), 
the disease would be controlled effectively and the prevalence decreased to 
minimal levels. In this situation, decision-makers can then move to a more ad-
vanced eradication strategy. In that case, the sequence of events should always 
follow a logical trail avoiding backward steps. 
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 1. Bucellosis-free status 
 Once brucellosis prevalence has been decreased to minimal levels by 
the repeated mass vaccination of the population over the years, and provided 
that the veterinary infrastructure and economic resources are also improved in 
parallel, eradication may then be feasible. This could be achieved through the 
implementation of a very complex and expensive programme based on the com-
bination of the vaccination of young replacement animals (3–4 months old, by 
the conjunctival method exclusively) with the test and slaughter of adults found 
seropositive. As basic but imperative complementary tools, the adequate indivi-
dual identification of all animals and the effective control of all animal move-
ments would be implemented in the defined epidemiological unit of interven-
tion. The basic principle of eradication is to avoid the entry of infected animals 
into healthy flocks. Accordingly, the strict control of animal movements is of 
paramount importance, and probably one of the most problematic issues faced 
by the veterinary services involved in eradication programmes applied to any of 
the relevant animal diseases. The successful application of this sophisticated 
and very expensive combined programme for at least one entire generation (6–
12 years, depending on the animal species and breeding systems considered) co-
uld lead to a zero or close to zero prevalence, and then to a generalised brucel-
losis-free status in the epidemiological unit involved. In a final step, the ban on 
Rev 1 vaccination and the application of an exclusive test and slaughter progra-
mme (applying either partial or full depopulation of infected flocks) could lead 
to obtaining brucellosis officially-free status. 
 Once brucellosis has been controlled by Rev 1 based mass vaccination, 
the implementation of a combined eradication programme should be the next 
logical step. Since the serological response induced by Rev 1 in adult vaccina-
ted animals is of higher intensity and duration than that induced in young repla-
cements [26], the interpretation of serological results during the passage from 
mass vaccination to a combined eradication programme is critical to avoid the 
unnecessary culling of healthy but seropositive animals. Taking this important 
fact into consideration, two technical possibilities could be applied when mo-
ving from a control programme based on mass vaccination to a combined eradi-
cation programme, whose efficacy has been demonstrated in some regions in 
Spain (JM Blasco, unpublished results): 
  
 
A. Avoid serological testing of the animals for a period of two years 
after stopping mass vaccination 
 
 The main objective is to avoid the excessive culling of healthy but se-
ropositive adult vaccinated animals. This is not a trivial point since the serolo-
gical background of mass vaccinated animals, living in an infected environment, 
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it is not easy to interpret. Even when applied conjunctivally, the serological res-
ponse induced by Rev 1 in adult animals is of significantly higher intensity and 
duration than that induced in young replacements, making the interpretation of 
serological results extremely cumbersome [26]. Moreover, as indicated above, 
this situation becomes even more complicated because the Rev 1 immunised 
animals living in an infected environment can produce anamnestic responses 
after having antigenic contacts with B. melitensis infected materials, with the 
ensuing development of high and persistent antibody titers even in the case of 
being protected against these repeated field challenges. In these conditions, very 
high numbers of animals should be culled when implementing a serological tes-
ting using the classical RB and CF tests. Therefore, this strategy is unfeasible 
(depending on the prevalence of prior vaccination, figures as high as 15–50% of 
the population would result in positive CF titers several months after vaccina-
tion), and this is the reason to recommend avoiding the serological testing of the 
population for a given time (at least two years) after a mass vaccination is imp-
lemented. Accordingly, the only interventions to be applied during these two 
first years after stopping mass vaccination would be the following: 
 a) the exhaustive individual identification and vaccination (conjunctival 
procedure) of 100% of young replacements (both males and females, and ide-
ally when 3–4 months old – it is never recommended to vaccinate animals older 
than 4 months because the older the animals vaccinated, the longer the serologi-
cal response induced), with the compulsory implementation of owner registries, 
on which the new replacement animals should be compulsorily recorded. 
 b) the entire individual identification of the whole population and the 
establishment of a compulsory system for movement control. This seems an 
easy task, but experience in many countries demonstrates that succeeding in the 
effective control of the movements of the entire animal population is extremely 
difficult and requires suitable identification procedures, a perfect administrative 
organisation of the veterinary services involved and, of course, the active colla-
boration of farmers. 
 Once this period of two years is over, it would be expected that many 
infected animals (vaccination has no therapeutic effects in previously infected 
animals) would have disappeared by natural replacement, and moreover, the se-
rological background in the population should have been significantly reduced. 
Then, the compulsory individual testing of all adult animals (over 12–16 mon-
ths of age: i.e. the first central pair of permanent teeth are present; therefore, the 
new born and the recently vaccinated young replacements should not be tested) 
using the RB test as screening, with the ensuing culling of animals positive in 
the CF test (considering 30 IU as the cut-off), would be recommended as com-
plementary to measures i) and ii) indicated above. All flocks having at least one 
CF positive animal should be retested as quickly as possible and as many times 
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as necessary until at least two consecutive negative CF test results are obtained 




B. Immediate testing and culling of seropositive animals after stopping 
mass vaccination 
 
 As indicated above, the serological background of mass vaccinated 
animals is not easy to interpret due to the serological responses induced by Rev 
1 and the secondary anamnestic responses produced in infected environments. 
In these conditions, none of the immunological tests available is able to identify 
with 100% accuracy the responses induced exclusively in the truly infected 
animals. Only gel precipitation tests with Native Hapten (NH) antigen [27, 28] 
are able to identify with an acceptable level of accuracy the serological respon-
ses induced by the truly infected animals [26]. Accordingly, 6–12 months after 
mass vaccination is stopped, the NH gel precipitation testing and culling of 
seropositives could be implemented in all animals of over 12–16 months of age, 
with the main objective of accelerating the elimination of infected animals and 
lowering the serological background of the population (the lower the number of 
infected animals present in the environment, the fewer anamnestic responses 
will be produced, then the serological background of the population will be 
reduced progressively). This serological testing should be repeated as frequently 
as possible (and at the shortest intervals possible) in each flock identified as in-
fected until at least two consecutive negative NH tests are obtained. Of course, 
measures a) and b) indicated above should also be implemented compulsorily. 
Once the percentage of animals seropositive in NH gel precipitation tests is zero 
in at least two consecutive samplings, the testing schedule could be modified 
using the classical RB and CF testing. This strategy could be maintained for 
years (at least one entire generation) until reaching and maintaining a preva-
lence close or equal to zero, and then reaching the brucellosis-free status. 
  Without any reasonable doubt, this brucellosis-free status obtained 
using either A or B possibilities above, is the most recommendable eradication 
strategy from the technical standpoint since the disease could be fully eradicated 
but the animals will yet be immunised, thus being capable of resisting infection 
caused by accidental reintroduction from neighbouring epidemiological units 
still infected. 
 When this extremely favourable situation is maintained for at least one 
entire generation, an exclusive test and slaughter programme with a ban on 
vaccination could then be applied with the objective of getting the brucellosis 
officially-free status.  
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 2. Bucellosis offically-free status 
 This status is required by many countries for international animal trade 
purposes, and it should be recommended only in the case where farmers need 
that trade for an adequate income. It is quite difficult to understand that many 
countries have implemented eradication via this officially-free strategy rather 
than via brucellosis-free, in a total absence of farmers dedicated to exporting 
live animals to international markets. This is even more surprising when this si-
tuation happens in countries which have not fully eradicated the disease and, 
therefore, banned Rev 1 prematurely, accepting important risks of reintroduc-
tion of brucellosis infection in animals from infected to free regions. The recent 
example of Greece should be taken into consideration: after Rev 1 was banned 
bearing in mind the apparent good epidemiological situation, mass vaccination 
had to be implemented again several years later due to an important increase in 
brucellosis prevalence. Vaccination should be banned only when a generalised 
brucellosis-free status has been obtained in the whole epidemiological unit con-
sidered and, importantly, when this situation remains unchanged for many years. 
The premature banning of vaccination is the most frequent error of decision-
makers in many countries during the latter stages of combined eradication prog-
rammes (as an example, the Rev 1 and S19 vaccines were recently banned in 
some Spanish regions, despite collective prevalence in some bordering regions 
being high, and this caused many relapses). As a general rule, vaccination 
should never be abandoned in a given epidemiological unit: 1) there is a generali-
sed need of the officially-free status for access to international markets, 2) the 
collective prevalence is zero in the whole epidemiological unit, 3) this favou-
rable situation is maintained with an absence of new cases during at least one 
entire generation (6–12 years, depending on the animal species and breeding 
systems considered), and 4) the risk of transmission or reintroduction of the disease 
from infected neighbouring epidemiologically related units is also negligible. 
 Once vaccination is forbidden, the detection of positive animals in an 
adequate repetitive context by means of the proper diagnostic tests (i.e. associa-
tions RB + CF, indirect ELISA + CF, or indirect ELISA alone) and their imme-
diate culling, could allow the generalised officially-free status. In this advanced 
stage, it is recommended that test results have a collective rather than an indivi-
dual interpretation. The whole culling of flocks detected as infected is frequ-
ently more practical and effective than the partial culling of only the infected 
animals identified. These latter stages of eradication also have plenty of techni-
cal difficulties: particularly remarkable is the over-killing of healthy animals as 
a consequence of the lack of specificity of serological tests in low prevalence 
situations. Moreover, this problem has dramatically increased in many official-
ly-free countries as a consequence of the false positive serological responses 
due to Yersinia enterocolitica O:9 and other bacteria inducing cross-reactive 
antibodies against the S-LPS of Brucella [29]. 
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 It is important to take into consideration that to be successful in obtai-
ning either the brucellosis-free or the officially-free status, a perfect administra-
tive organisation, the individual identification of each animal and the exhaustive 
control of animal movements, an adequate budget, and the active cooperation of 





 When the disease has been fully eradicated from a given epidemiolo-
gical unit (thus obtaining free or officially-free status), a surveillance system has 
to be implemented to detect eventual new outbreaks or reintroduction. Passive 
surveillance systems based, for example, on the compulsory declaration by far-
mers of abortions produced are not suitable and have proved ineffective for the 
early detection of new outbreaks of disease. Therefore, an active surveillance 
system is always recommendable. In the case of small ruminants, active surveil-
lance could be based on the regular serological screening (RB or i-ELISA could 
be the most recommendable tests for this purpose) of a representative sample of 
the population. The use of generalist and empiric sampling rules (for example, 
some EU countries test only 25% of adult females in a three-year interval for 
maintenance of the officially-free status) should be avoided. It is always recom-
mendable to test regularly (once a year should be the minimum) a representative 
sample of the population considered, whose composition should also be calcula-
ted using adequate epidemiological software having in mind the number of flocks, 
the average number of animals per flock and, importantly, the threshold level of 





 B. melitensis infection is responsible for brucellosis in sheep and goats, 
and the primary cause of brucellosis in human beings. Whenever possible, the 
eradication of this infection in sheep and goats should be the final objective of 
any control programme to be implemented, no matter what the extension of the 
epidemiological unit considered. In absolute terms, “eradication” means the to-
tal elimination of the pathogen involved from the country or region considered. 
Accordingly, eradication is frequently inapplicable in high prevalence situations 
and extensive breeding systems, and a control programme is then the only fea-
sible strategy. We can define “control” as the reduction of the prevalence to a 
minimum, with the objective of limiting the main consequences of disease. The-
refore, the concept “controlled” could be equivalent to “minimisation of the di-
sease effects”. The selection of an eradication or control strategy is of paramo-
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unt relevance, and a frequent cause of controversy among decision-makers. Be-
fore any decision can be taken, and as a condition sine qua non, the quality and 
organisation of the veterinary services involved should be properly assessed (ot-
herwise, no strategy can be applied). Whenever the organisation of veterinary 
services is adequate, the final strategy should be established according to the 
economic resources available and the extent and prevalence of disease. The eco-
nomic costs of eradication programmes are very high, and plenty of money has 
to be available along with other elementary conditions required for the selection 
of any eradication strategy. Experience in countries that succeed with eradica-
tion has demonstrated beyond doubt that the eradication programmes cannot be 
implemented without farmers’ cooperation and if adequate economic compensa-
tions to affected farmers are not provided. Only when the above conditions are 
fulfilled, and whenever brucellosis prevalence in the epidemiological unit con-
cerned is very low and uniform, can short term eradication through an exclusive 
test and slaughter programme without vaccination be considered. In the same 
favorable socioeconomic situation but having a moderate or not homogeneous 
disease prevalence, a combined eradication strategy based on young replace-
ment vaccination (using Rev 1 by the conjunctival route) and a test and slaugh-
ter programme in adult animals could be recommended. However, when brucel-
losis is highly prevalent, and independently of the socioeconomic situation con-
sidered, the application of eradication programmes is generally unfeasible. In 
these conditions, the mass (whole-flock) vaccination of all susceptible animals 
from all animal species involved in the epidemiological cycle is the only reaso-
nable alternative to control the disease. Moreover, this mass-vaccination progra-
mme is the basic strategy to be applied over probably several generations in 
countries with elementary veterinary services and few economic resources, with 
the main objective of lowering the prevalence of the disease. Once the disease 
has been controlled effectively (i.e. prevalence has been decreased to a mini-
mum and this favourable situation maintained for at least one entire generation), 
and when the veterinary services organisation and economic resources are im-
proved in parallel, a shift towards eradication may be recommended. This can 
be achieved through a combined eradication programme based on the vaccina-
tion of young replacements and the test and slaughter of adult animals as above. 
The successful application of this combined programme for at least one entire 
generation (6–12 years, depending on the breeding systems and animal species 
involved) could lead to a collective prevalence (percentage of infected flocks) 
close to zero, and then to a generalised brucellosis-free status in the epidemiolo-
gical unit considered. Once this has been accomplished, and this favourable si-
tuation maintained for at least one additional entire generation, the ban on vac-
cines and the application of an exclusive test and slaughter programme could 
lead to a generalised officially-free brucellosis status. Once the effective control 
of the disease has been accomplished and eradication becomes feasible, the 
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premature ban on vaccination to obtain this officially-free status (frequently 
required for international trade) is one of the most common errors of decision-
makers. As a general rule, vaccination should be abandoned only when the col-
lective prevalence is zero, this situation maintained during at least one entire ge-
neration, and also the risk of transmission or reintroduction of the disease from 
infected neighbouring epidemiologically related units is negligible. In addition 
to the availability of huge amounts of money and the full agreement of the far-
mers involved, to be successful in obtaining either brucellosis-free or officially-
free status, a perfect administrative organisation, full individual identification of 
animals and exhaustive control of animal movements will be compulsory. Once 
the disease has been fully eradicated from a given epidemiological unit, a sur-
veillance strategy has to be implemented for the early detection of eventual new 
outbreaks or disease reintroduction.  
 It is important to stress that in many countries with extensive or tran-
shumant breeding systems, both small ruminants and cattle (and frequently also 
camels, yaks and buffaloes) are reared together, and that these animal species 
can be infected by B. melitensis. In these epidemiologically complex situations 
the application of any sanitary strategy should cover the different animal species 
involved in the epidemiological cycle. Unfortunately, knowledge of the value of 
the diagnostic and prophylactic tools for brucellosis in camels, yaks and buffa-
loes is non-existent or very limited. It is frequently considered that the diagno-
stic and prophylactic tools applied in small ruminants and cattle are equally 
effective in these animal species, but this has never been adequately proved. Ac-
cordingly, a research effort should be made in the coming years to determine the 
precise role played by these animal species in B. melitensis epidemiology and 
the most effective diagnostic and prophylactic tools in these species. 
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R e z i m e  
STRATEGII ZA KONTROLA I ERADIKACIJA NA INFEKCIITE 




Edinica za zdravje na `ivotnite CITA (Unidad de Sanidad Animal, Gobierno de 
Aragón) Saragoza, [panija 
 
 
Cel: Da se opi{at razli~ni strategii za kontrola i eradikacija na 
infekciite so B. melitensis kaj ovcite i kozite. 
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Metodi: Prednostite i lo{ite strani na razli~ni strategii se 
diskutiraat vrz osnova na li~noto iskustvo na avtorot, kako i so pregled 
na relevantna literatura.  
Rezultati: Programite za vakcinacija vo razli~ni kombinacii 
mo`e da se primenuvaat za namaluvawe na prevalencata na infekcijata 
pome|u `ivotnite, ili mo`e da se kombiniraat so adekvatni dopolnitelni 
eradikacioni merki za da se postigne iskorenuvawe na brucelozata.  
Zaklu~ok: Kontroliraweto na bolesta treba da bide primarnata 
cel na vklu~enite veterinarni slu`bi i institucii. Sepak, eradikacijata 
treba da bide kone~nata cel na sekoja implementirana programa za kon-
trola. Odbiraweto na strategija za kontrola ili eradikacija e od klu~na 
va`nost, a ~esto e pri~ina za kontroverzi pome|u nositelite na odluki. 
Kone~nata strategija bi trebalo da se napravi soglasno kvalitetot i orga-
nizacijata na veterinarnite slu`bi, raspolo`livite finansiski sredstva 
i ra{irenosta i prevalencata na bolesta. Sorabotkata so farmerite e 
klu~na za postignuvawe uspeh duri i pri sproveduvaweto i na najednostav-
nite kontrolni programi. Koga brucelozata e mnogu zastapena, masovnata 
(na celo stado) vakcinacija e najdobar izbor, nezavisno od socioekonom-
skata situacija. Koga }e se postigne efektivna kontrola na bolesta, eradi-
kacijata e ostvarliva. Za uspe{na eradikacija, neophodna e adekvatna i 
kvalitetna organizacija na veterinarnite slu`bi, stroga kontrola na dvi-
`eweto na `ivotnite i zadol`itelno obezbeduvawe na adekvatna ekonom-
ska kompenzacija na zasegnatite farmeri. Koga bolesta e kompletno eradi-
cirana, mora da bide implementirana strategija za sledewe/nadzor zaradi 
rano otkrivawe na eventualno povtorno razgoruvawe na bolesta.  
 
Klu~ni zborovi: bruceloza, Brucella melitensis, zoonoza, vakcinacija, strate-
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